119-S-2355 Journalist Public Summary

Headline Summary

A bipartisan push to make medical prices and insurance payments easier to see, compare, and verify—so patients know what they’ll owe, employers can audit costs, and bad actors face real penalties.

What It Does

In plain English: the bill would expand and standardize healthcare price transparency and add teeth to enforcement. Here are the major pieces:

• Hospitals: Must post monthly, standard, machine‑readable price lists and easy‑to‑use consumer pages covering at least 300 “shoppable” services through 2026, then all shoppable services. They must show list prices, discounted cash prices (which any patient can elect to pay), payer‑specific negotiated rates, and even the formulas used to compute them. Senior executives must attest to accuracy; annual compliance checks are required; penalties escalate—especially for large, persistently noncompliant hospitals.
• Clinical labs, imaging providers, and certain hospital‑affiliated ambulatory surgery centers (ASCs): Brought under similar transparency rules with standardized data formats and per‑day penalties for noncompliance. Labs and imaging start July 1, 2027; specified ASCs post annual machine‑readable files and consumer‑friendly lists.
• Insurers and health plans: Must run a real‑time, self‑service cost tool that shows an in‑network price (or the max allowed out‑of‑network amount), your cost‑sharing, and any prior authorization rules—and must hold members harmless if the tool underestimates what the member owes. Plans must also publish monthly machine‑readable files for in‑network rates, historical out‑of‑network allowed amounts, and drug pricing (including net prices after rebates). Officers must attest; federal agencies must audit and report to Congress annually.
• Employer plans’ access to data: Bars “gag clauses” and requires third‑party administrators, networks, and pharmacy benefit managers to give plans timely access to claims, payment, and contract terms in standard HIPAA transaction formats (e.g., X12 837/835; NCPDP), with steep daily penalties for stonewalling. Restrictive contract terms are deemed void as against public policy.
• Patient protections on bills: Requires itemized, plain‑language medical bills with billing codes and charity‑care info within 30 days after the provider receives a final third‑party payment. Collection actions are limited, and a good‑faith estimate is binding unless the provider documents unforeseen, medically necessary changes.
• Explanation of Benefits (EOB): Starting in 2026, plans must send an itemized EOB within 45 days of receiving a claim, showing what the plan paid, what the patient owes, where care occurred, and updated progress toward deductibles/out‑of‑pocket limits.
• State laws: Keeps stronger state transparency rules in place unless they directly conflict with this Act.
• Effective dates (high level): Most hospital/plan provisions begin January 1, 2026; labs, imaging, and specified ASCs post starting July 1, 2027; new data‑access duties for service providers phase in one to two years after enactment depending on the section.

Who’s For It

• Bill sponsors: Sens. Roger Marshall (R‑KS), John Hickenlooper (D‑CO), Chuck Grassley (R‑IA), Maggie Hassan (D‑NH), Tim Sheehy (R‑MT), and Joni Ernst (R‑IA) signal bipartisan backing.
• Patient and consumer advocates who want upfront prices, binding estimates, and itemized bills.
• Large and mid‑size employers, unions, and benefits coalitions seeking full claims and contract data to control spending and audit vendors.
• Market‑competition and transparency groups that argue sunlight deters price gouging and hidden fees.

Who’s Against It

• Hospitals and health systems may argue that monthly posting, executive attestations, and high penalties are burdensome and risk misinterpretation of complex pricing.
• Health insurers and pharmacy benefit managers may resist public disclosure of negotiated rates, rebate data, and algorithms, calling them proprietary and warning of higher prices if competitors can see tactics.
• Some specialty providers (labs, imaging, ASCs) may raise administrative‑cost and data‑standard concerns, especially for smaller or rural facilities.
• Privacy and cybersecurity advocates may warn that more data files increase exposure risk if not implemented carefully—even when de‑identified and standardized.
• States and regulators could flag preemption or coordination issues where existing state transparency rules differ in format or scope.

What’s Next

Status as of March 20, 2026: The bill was introduced and referred to the Senate HELP Committee on July 17, 2025; the HELP Committee held a hearing on March 19, 2026. Next steps would typically be a committee markup and vote, possible Senate floor consideration, House action, and then the President’s desk if both chambers pass the same text.

Key Numbers

Tone

Neutral, factual, and easy to read—aimed at giving a typical voter a quick, accurate picture without insider jargon.